(REal Safety and Efficacy of a 3-month dual antiplatelet Therapy following E-ZES implantation NCT01145079).Ĭopyright © 2012 American College of Cardiology Foundation. The rates of target vessel revascularization were 3.9% and 3.7%, respectively (difference: 0.2% 95% CI: -2.3 to 2.6 p=0.70).Į-ZES+3-month DAPT was noninferior to the standard therapy with respect to the occurrence of the primary endpoint. The rates of stent thrombosis were 0.2% and 0.3%, respectively (difference: -0.1% 95% CI: -0.5 to 0.3 p=0.65) without its further occurrence after cessation of clopidogrel in the E-ZES+3-month DAPT group. The composite rates of any death, myocardial infarction, or stent thrombosis were 0.8% and 1.3%, respectively (difference: -0.5% 95% CI: -1.5 to 0.5 p=0.48). The primary endpoint occurred in 40 (4.7%) patients assigned to E-ZES+3-month DAPT compared with 41 (4.7%) patients assigned to the standard therapy (difference: 0.0% 95% confidence interval : -2.5 to 2.5 p=0.84 p<0.001 for noninferiority). Based on those options alone I prefer Odrive since I can test drive it as long as I want. Click the Connect button to establish a connection with the ExaVault account.
Specify your ExaVault server’s address, username, and password, like: 3.
#EXPANDRIVE RESET TRIAL FREE#
Odrive: Unlimited use of the free edition which makes available many core features but does leave out some important ones like encryption that come with a monthly subscription fee. Open the ExpanDrive window and click on the New Drive button and select the SFTP or FTP drive type.
#EXPANDRIVE RESET TRIAL TRIAL#
This will help alleviate issues where dropped connections are reset by FileZilla but not. ExpanDrive: 30 day trial with flat purchase fee. We hypothesized that the E-ZES+3-month DAPT would be noninferior to the standard therapy for the primary composite endpoint (cardiovascular death, myocardial infarction, stent thrombosis, target\vessel revascularization, or bleeding) at 1 year. To resolve, you can optimize a few settings in FileZilla. We randomly assigned 2,117 patients with coronary artery stenosis into 2 groups according to DAPT duration and stent type: 3-month DAPT following Endeavor zotarolimus-eluting stent (E-ZES) implantation (E-ZES+3-month DAPT, n=1,059) versus 12-month DAPT following the other DES implantation (standard therapy, n=1,058). i do have the same problem, changing back the date didn't help. The previous trial has expired.' I have tried a new email. There have been few published reports of prospective randomized clinical studies comparing the safety and efficacy of shorter duration DAPT after DES implantation. I had to format my Mac & now I get 'We cannot offer you a new trial because a trial period has already been requested from this Mac.
The goal of this study was to evaluate shorter duration (3 months) dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation.
0 kommentar(er)
